Visalytics
Visalytics
approved EB-2 (NIW)

Resident Physician

Internal Medicine · 2025-07-21

Processing Time
5 days
Decision Date
2025-07-21
Location
Pennsylvania
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research into regenerative gene therapy for advanced heart failure, focusing on uncovering molecular mechanisms and improving outcomes for patients with ischemic myocardial disease. Her work involves studying structural and functional changes in the myocardium under ischemic stress to develop methods for cardiac regeneration and survival.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses heart failure, a major U.S. health concern and leading cause of death.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a strong record of peer-reviewed publications, citations, and editorial experience.

3 Waiver of Job Offer and Labor Certification Met

The petitioner's contributions to medical innovation and public health justify a waiver of the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's 10 peer-reviewed publications and 9 abstracts, which garnered 47 citations from independent researchers. Her work includes articles ranked in the top 20% of most-cited papers in Clinical Medicine, and she demonstrated editorial experience as a managing editor for a peer-reviewed journal.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Original Contributions

Similar Cases

Assistant Professor

Research and Development · India

WeGreened EB-2 (NIW) approved
North Carolina 121 days 2026-01-21
The petitioner proposes to investigate cardiac physiology in the context of heart failure using mouse models to facilitate successful therapeutic interventions for cardiovascular diseases. The work focuses on identifying therapeutic targets and evaluating pharmacological compounds and cell-derived products to improve treatment pathways. This research aims to provide actionable insights into how heart failure develops and progresses to support translational decision-making.
View Case

Postdoctoral Researcher

Research and Development · Bangladesh

WeGreened EB-2 (NIW) approved
Louisiana 63 days 2022-04-13
The petitioner proposes to continue discovering and characterizing molecular receptors, genes, proteins, and cellular pathways that protect cardiomyocytes against heart failure stressors. The work focuses on developing novel treatments for heart failure-inducing pathological stressors such as diabetes, chemotherapy, methamphetamine use, and deleterious genetic mutations.
View Case

Others

Healthcare · Greece

WeGreened EB-2 (NIW) approved
Massachusetts 37 days 2025-11-13
The petitioner proposes to conduct clinical and translational research focused on identifying predictors of myocardial recovery in patients with advanced heart failure supported by mechanical circulatory devices. The work aims to evaluate the durability of recovery following device explant and develop clinical strategies to reduce mortality and hospital readmissions.
View Case

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
7 days 2023-10-30
The petitioner proposes to continue her research identifying specific genes and proteins that protect against myocardial infarction and studying the progression of allograft vasculopathy. Her work focuses on developing therapeutics for heart disease and improving the long-term success rates of heart transplantation procedures.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-21.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 5 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist